17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.

Odibo AO, Stamilio DM, Macones GA, Polsky D. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):492-9.

View in: PubMed

subject areas

Cost-Benefit Analysis
Decision Support Techniques
Female
Gestational Age
Health Care Costs
Hospitalization
Humans
Hydroxyprogesterones
Multivariate Analysis
Obstetric Labor Complications
Obstetric Labor, Premature
Parity
Pregnancy
Premature Birth
Progestins
Risk Factors
Secondary Prevention
United States

authors with profiles

David M. Stamilio MD, MS